Ellington Management Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,760
| Closed | -$301K | – | 637 |
|
|
2019
Q1 | $301K | Buy |
+5,760
| New | +$301K | 0.05% | 339 |
|
|
2017
Q3 | – | Sell |
-7,920
| Closed | -$427K | – | 702 |
|
|
2017
Q2 | $427K | Buy |
+7,920
| New | +$427K | 0.06% | 286 |
|
|
2017
Q1 | – | Sell |
-12,480
| Closed | -$601K | – | 749 |
|
|
2016
Q4 | $601K | Buy |
12,480
+5,360
| +75% | +$258K | 0.09% | 167 |
|
|
2016
Q3 | $384K | Buy |
+7,120
| New | +$384K | 0.11% | 370 |
|
|
2016
Q2 | – | Sell |
-5,120
| Closed | -$260K | – | 345 |
|
|
2016
Q1 | $260K | Buy |
5,120
+480
| +10% | +$24.4K | 0.11% | 273 |
|
|
2015
Q4 | $234K | Buy |
+4,640
| New | +$234K | 0.08% | 382 |
|
|
2014
Q2 | – | Sell |
-4,240
| Closed | -$283K | – | 538 |
|
|
2014
Q1 | $283K | Buy |
+4,240
| New | +$283K | 0.08% | 380 |
|